Overview
Vishnu Veeraraghavan-Priya practices practicing medicine in Chennai, India.
His clinical expertise encompasses Glossitis and Head and Neck Squamous Cell Carcinoma (HNSCC).
He is actively involved in clinical research, co-authoring 14 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Vishnu Veeraraghavan-Priya
Is Vishnu Veeraraghavan-Priya a top-rated expert for Glossitis?
MediFind is an objective health platform that identifies experts based on real-world data. Vishnu Veeraraghavan-Priya is classified as an Experienced expert for Glossitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Vishnu Veeraraghavan-Priya participate in research or clinical trials?
Yes. Vishnu Veeraraghavan-Priya has published 14 articles and abstracts on conditions like Glossitis. You can view a list of Vishnu Veeraraghavan-Priya's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- GlossitisMr. Veeraraghavan-Priya isExperienced. Learn about Glossitis.
- Head and Neck Squamous Cell Carcinoma (HNSCC)Mr. Veeraraghavan-Priya isExperienced. Learn about Head and Neck Squamous Cell Carcinoma (HNSCC).